He Y, Lin Y, Song J, Song M, Nie X, Sun H
Cell Commun Signal. 2025; 23(1):125.
PMID: 40055721
PMC: 11889974.
DOI: 10.1186/s12964-025-02121-2.
Termite F, Archilei S, DAmbrosio F, Petrucci L, Viceconti N, Iaccarino R
Antioxidants (Basel). 2025; 14(1).
PMID: 39857390
PMC: 11759774.
DOI: 10.3390/antiox14010056.
Mao T, Xu X, Liu L, Wu Y, Wu X, Niu W
J Transl Med. 2024; 22(1):1119.
PMID: 39707364
PMC: 11662811.
DOI: 10.1186/s12967-024-05865-6.
Ran X, Wang Y, Li S, Dai C
Lipids Health Dis. 2024; 23(1):401.
PMID: 39696288
PMC: 11654016.
DOI: 10.1186/s12944-024-02391-8.
Rogalski J, Tomczak T
Postep Psychiatr Neurol. 2024; 33(3):178-187.
PMID: 39678457
PMC: 11635434.
DOI: 10.5114/ppn.2024.142136.
Gut microbiota in health and disease: advances and future prospects.
Zhang Y, Wang H, Sang Y, Liu M, Wang Q, Yang H
MedComm (2020). 2024; 5(12):e70012.
PMID: 39568773
PMC: 11577303.
DOI: 10.1002/mco2.70012.
A screening study of high-risk groups for liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease.
Chao G, Zhu Y, Bao Y
Sci Rep. 2024; 14(1):23714.
PMID: 39390119
PMC: 11467177.
DOI: 10.1038/s41598-024-74792-9.
Peripheral inflammation as a potential mechanism and preventive strategy for perioperative neurocognitive disorder under general anesthesia and surgery.
Li Y, Li Y, Fang X, Chen D, Yu W, Zhu Z
Front Cell Neurosci. 2024; 18:1365448.
PMID: 39022312
PMC: 11252726.
DOI: 10.3389/fncel.2024.1365448.
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.
Boldys A, Buldak L
World J Gastroenterol. 2024; 30(18):2387-2390.
PMID: 38764762
PMC: 11099391.
DOI: 10.3748/wjg.v30.i18.2387.
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway.
Ji J, Cheng Z, Zhang J, Wu J, Xu X, Guo C
J Cell Mol Med. 2024; 28(8):e18335.
PMID: 38652216
PMC: 11037408.
DOI: 10.1111/jcmm.18335.
Underlying Mechanisms behind the Brain-Gut-Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.
De Col J, de Lima E, Pompeu F, Cressoni Araujo A, de Alvares Goulart R, Bechara M
Int J Mol Sci. 2024; 25(7).
PMID: 38612504
PMC: 11011299.
DOI: 10.3390/ijms25073694.
Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: A case-control study.
Gan L, Xia C, Zhu X, Gao Y, Wu W, Li Q
World J Diabetes. 2024; 15(3):418-428.
PMID: 38591072
PMC: 10999044.
DOI: 10.4239/wjd.v15.i3.418.
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications.
Wu Z, Zhu Y, Liu W, Balasubramanian B, Xu X, Yao J
Antioxidants (Basel). 2024; 13(3).
PMID: 38539886
PMC: 10968642.
DOI: 10.3390/antiox13030352.
Sodium Butyrate Alleviates Free Fatty Acid-Induced Steatosis in Primary Chicken Hepatocytes via Regulating the ROS/GPX4/Ferroptosis Pathway.
Cheng X, Hu Y, Yu X, Chen J, Guo X, Cao H
Antioxidants (Basel). 2024; 13(2).
PMID: 38397738
PMC: 10886346.
DOI: 10.3390/antiox13020140.
Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients: a retrospective cohort study.
Li Z, Wu X, Chen Z, Wei X, Chen W
Gastroenterol Rep (Oxf). 2024; 12:goad076.
PMID: 38264763
PMC: 10805339.
DOI: 10.1093/gastro/goad076.
Use of a ferroptosis-related gene signature to construct diagnostic and prognostic models for assessing immune infiltration in metabolic dysfunction-associated fatty liver disease.
Lian X, Tang X
Front Cell Dev Biol. 2023; 11:1199846.
PMID: 37928903
PMC: 10622674.
DOI: 10.3389/fcell.2023.1199846.
Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation.
Li J, Dai W, Mo W, Xu W, Li Y, Guo C
J Clin Transl Hepatol. 2023; 11(6):1341-1354.
PMID: 37719959
PMC: 10500289.
DOI: 10.14218/JCTH.2023.00133.
Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway.
Guan Q, Wang Z, Hu K, Cao J, Dong Y, Chen Y
Int J Biol Sci. 2023; 19(12):3937-3950.
PMID: 37564204
PMC: 10411470.
DOI: 10.7150/ijbs.85883.
Synergistic Effect of Diet and Physical Activity on a NAFLD Cohort: Metabolomics Profile and Clinical Variable Evaluation.
Calabrese F, Celano G, Bonfiglio C, Campanella A, Franco I, Annunziato A
Nutrients. 2023; 15(11).
PMID: 37299420
PMC: 10255762.
DOI: 10.3390/nu15112457.
Cholangiokines: undervalued modulators in the hepatic microenvironment.
Cai X, Tacke F, Guillot A, Liu H
Front Immunol. 2023; 14:1192840.
PMID: 37261338
PMC: 10229055.
DOI: 10.3389/fimmu.2023.1192840.